FeesSafety
Pluang+

Aebi Schmidt Group reports Q3 2026 sales and profit growth despite inflation and supply challenges.

Company Fundamentals
11 Nov 2026, 14:00 WIB
GlobeNewsWire
View Source
Bullish
Aebi Schmidt Group reports Q3 2026 sales and profit growth despite inflation and supply challenges.

Aebi Schmidt Group posted a 4.6% increase in Q3 2026 net sales to $493 million and a 9-fold rise in net income to $10.8 million compared to Q3 2025. Growth was driven by strong demand in North America, especially in Walk-In Vans and Municipal sectors, despite challenges from inflation, geopolitical tensions, and supply chain disruptions. The company improved adjusted EBITDA by 4.9% and reduced net debt, while updating its full-year 2026 guidance with slightly lower sales and EBITDA expectations due to ongoing market headwinds. Aebi Schmidt also announced plans to acquire O.J. Watson Company to expand its North American presence.

Aebi Schmidt Group's recent financial performance and outlook update provide context for readers. For those tracking Industrials-sector stocks, 91 of 135 US stocks rose while 39 fell on Pluang. Notable movers include BYRN at USD 4.47 with a 7.45% increase, INIO at USD 14.67 up 6.54% with 100% buy order activity, and MOD at USD 109.78 rising 6.51%. Data is as of Nov 11, 2026 18:41 WIB.

More News

NRx Pharmaceuticals launches U.S.-made preservative-free ketamine to address long-standing shortage.

NRx Pharmaceuticals launches U.S.-made preservative-free ketamine to address long-standing shortage.

NRx Pharmaceuticals has begun selling a new preservative-free ketamine made in the U.S., addressing a shortage that has persisted since 2018. This ketamine uses innovative blow-fill-seal technology, eliminating the preservative benzethonium chloride,...

Market News
Bullish
1 hour ago
FLSmidth sets financial report and AGM dates for 2027, highlighting sustainability goals.

FLSmidth sets financial report and AGM dates for 2027, highlighting sustainability goals.

FLSmidth & Co. A/S announced its financial calendar for 2027, including key dates for the annual report, interim financial reports, and the annual general meeting. The company emphasizes its commitment to sustainability with its MissionZero goal to a...

Company Fundamentals
Neutral
2 hours ago
Dimensional Fund Advisors discloses 1.27% stake in Prologis Inc as of November 2026

Dimensional Fund Advisors discloses 1.27% stake in Prologis Inc as of November 2026

Dimensional Fund Advisors Ltd. has filed a Form 8.3 disclosure revealing it holds a 1.27% stake in Prologis Inc, totaling 12,054,886 shares as of November 10, 2026. This disclosure is part of regulatory requirements under the Takeover Code, indicatin...

Market News
Neutral
3 hours ago
Dimensional Fund Advisors discloses 1.61% stake in DCC Energy shares as of Nov 10, 2026

Dimensional Fund Advisors discloses 1.61% stake in DCC Energy shares as of Nov 10, 2026

Dimensional Fund Advisors Ltd. has filed a disclosure showing it holds a 1.61% stake in DCC Energy plc's ordinary shares as of November 10, 2026. The firm sold 42,998 shares recently at a price of £64.5585 each. This disclosure is part of regulatory ...

Market News
Neutral
3 hours ago
Novo Nordisk pledges $200M over 10 years to boost diabetes care in low-income countries

Novo Nordisk pledges $200M over 10 years to boost diabetes care in low-income countries

Novo Nordisk has committed $200 million to the World Diabetes Foundation for 2027–2036 to enhance diabetes prevention and care in low- and middle-income countries. This funding aims to improve equitable access to diabetes services in underserved comm...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App